139 related articles for article (PubMed ID: 2767619)
1. Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.
Thiele J; Zankovich R; Steinberg T; Fischer R; Diehl V
Hematol Oncol; 1989; 7(5):327-43. PubMed ID: 2767619
[TBL] [Abstract][Full Text] [Related]
2. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
Thiele J; Hoeppner B; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923
[TBL] [Abstract][Full Text] [Related]
3. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
[TBL] [Abstract][Full Text] [Related]
4. Myelofibrosis in chronic granulocytic leukaemia.
Clough V; Geary CG; Hashmi K; Davson J; Knowlson T
Br J Haematol; 1979 Aug; 42(4):515-26. PubMed ID: 289409
[TBL] [Abstract][Full Text] [Related]
5. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
Thiele J; Simon KG; Fischer R; Zankovich R
Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
[TBL] [Abstract][Full Text] [Related]
6. Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.
Thiele J; Chen YS; Kvasnicka HM; Diehl V; Fischer R
Leuk Lymphoma; 1994 Jun; 14(1-2):163-9. PubMed ID: 7920225
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
Michiels JJ; Thiele J
Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
9. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.
Colović MD; Wiernik PH; Janković GM; Vidović AD; Janosević S; Basara NM
Eur J Haematol; 1999 Mar; 62(3):155-9. PubMed ID: 10089892
[TBL] [Abstract][Full Text] [Related]
10. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
Thiele J; Steinberg T; Zankovich R; Fischer R
Anticancer Res; 1989; 9(2):429-35. PubMed ID: 2751268
[TBL] [Abstract][Full Text] [Related]
11. Secondary myelofibrosis with metastatic breast cancer simulating agnogenic myeloid metaplasia: report of a case and review of the literature.
Yablonski-Peretz T; Sulkes A; Polliack A; Weshler Z; Okon E; Catane R
Med Pediatr Oncol; 1985; 13(2):92-6. PubMed ID: 3982370
[TBL] [Abstract][Full Text] [Related]
12. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
Ohsaka A; Miura Y; Takahashi A; Yokoyama T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
[TBL] [Abstract][Full Text] [Related]
13. Myelosclerosis in agnogenic myeloid metaplasia.
Feldman F
Semin Roentgenol; 1974 Jul; 9(3):195-207. PubMed ID: 4601848
[No Abstract] [Full Text] [Related]
14. Agnogenic myeloid metaplasia in childhood: a report of two cases and efficiency of intravenous high dose methylprednisolone treatment.
Cetingül N; Yener E; Oztop S; Nisli G; Soydan S
Acta Paediatr Jpn; 1994 Dec; 36(6):697-700. PubMed ID: 7871986
[TBL] [Abstract][Full Text] [Related]
15. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
Varki A; Lottenberg R; Griffith R; Reinhard E
Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
[TBL] [Abstract][Full Text] [Related]
16. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
Ward HP; Block MH
Medicine (Baltimore); 1971 Sep; 50(5):357-420. PubMed ID: 4940717
[No Abstract] [Full Text] [Related]
17. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R
Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
Gianelli U; Fiori S; Cattaneo D; Bossi A; Cortinovis I; Bonometti A; Ercoli G; Bucelli C; Orofino N; Bulfamante G; Iurlo A
Histopathology; 2017 Dec; 71(6):897-908. PubMed ID: 28710830
[TBL] [Abstract][Full Text] [Related]
19. Progressive myelofibrosis in agnogenic myeloid metaplasia.
Lohmann TP; Beckman EN
Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
[TBL] [Abstract][Full Text] [Related]
20. Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.
Yachoui R; Kristianto J; Sitwala K; Blank RD
J Clin Endocrinol Metab; 2015 Nov; 100(11):3971-4. PubMed ID: 26358171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
